This particular test, referred to as DRUGMATRIX: GABAA and Flunitrazepam, examines central radioligand binding with the ligand [3H] Flunitrazepam. The testing organism used is Rattus norvegicus with strain Wistar, while the subcellular fraction used is the Membrane. The test is conducted in vitro on brain tissue and is described as a Binding assay. Does this molecule show efficacy in this assay?